Marinomed Biotech AG buy Savour
Start price
06.03.21
/
0%
€143.00
Target price
06.03.22
-
Performance (%)
-37.76%
End price
21.12.21
€89.00
Summary
This prediction ended on 21.12.21 with a price of €89.00. The BUY prediction by Savour for Marinomed Biotech AG performed very badly with a performance of -37.76%. This prediction was marked as speculative and is excluded from Savour's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Marinomed Biotech AG | - | - | - | - |
| iShares Core DAX® | -0,05 % | 5,96 % | 7,40 % | 65,85 % |
| iShares Nasdaq 100 | 0,92 % | 3,69 % | 28,14 % | 93,30 % |
| iShares Nikkei 225® | 3,01 % | 6,64 % | 48,89 % | 89,08 % |
| iShares S&P 500 | -0,36 % | 2,75 % | 22,53 % | 71,94 % |
According to Savour what are the pros and cons of Marinomed Biotech AG for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Savour for this prediction
In the thread Marinomed Biotech AG diskutieren
Buy Marinomed Biotech AG